FHIR Release 3 (STU) CI-Build

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0304.xml

Example MedicationAdministration/medadmin0304 (XML)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Ballot Standards Status : Informative Compartments : Device , Encounter , Group , Patient , Practitioner , RelatedPerson

Raw XML ( canonical form ) Jump past Narrative + also see XML Format Specification )

Intravenous Chemotherapy (Inpatient order) - Alemtuzumab - completed (id = "medadmin0304")

Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk(Details : {SNOMED CT code '47625008' = 'Intravenous route', given as 'Intravenous route (qualifier value)'})(Details : {SNOMED CT code '422145002' = 'Inject', given as 'Inject - dosing instruction imperative (qualifier value)'}) Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk 
<?xml version="1.0" encoding="UTF-8"?>

<MedicationAdministration xmlns="http://hl7.org/fhir">  <id value="medadmin0304"/>   <contained>     <Medication>       <id value="med0303"/>       <code>         <coding>           <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>           <code value="1594660"/>           <display value="alemtuzumab 10 MG/ML [Lemtrada]"/>         </coding>       </code>     </Medication>   </contained>   <status value="completed"/>   <medication>     <reference>       <reference value="#med0303"/>     </reference>   </medication>   <subject>     <reference value="Patient/pat1"/>     <display value="Donald Duck"/>   </subject>   <encounter>     <reference value="Encounter/f001"/>     <display value="encounter who leads to this prescription"/>   </encounter>   <occurrencePeriod>     <start value="2015-01-15T04:30:00+01:00"/>     <end value="2015-01-15T14:30:00+01:00"/>   </occurrencePeriod>   <performer>     <actor>       <reference>         <reference value="Practitioner/f007"/>         <display value="Patrick Pump"/>       </reference>     </actor>   </performer>   <reason>     <reference>       <reference value="Condition/f202"/>     </reference>   </reason>   <request>     <reference value="MedicationRequest/medrx0319"/>   </request>   <dosage>     <text value="Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to

     the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate
     days for up to 12 wk"/> 
    <route>       <coding>         <system value="http://snomed.info/sct"/>         <code value="47625008"/>         <display value="Intravenous route"/>       </coding>     </route>     <method>       <coding>         <system value="http://snomed.info/sct"/>         <code value="422145002"/>         <display value="Inject - dosing instruction imperative (qualifier value)"/>       </coding>     </method>     <dose>       <value value="3"/>       <unit value="mg"/>       <system value="http://unitsofmeasure.org"/>       <code value="mg"/>     </dose>   </dosage> 


</

MedicationAdministration

>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.